Elevation of Alpha-Fetoprotein in Sertoli-Leydig Cell Tumor: A Case Report
Keywords:
Sertoli-Leydig cell tumor, Alpha-fetoprotein, Hepatoid differentiation areasAbstract
Sertoli-Leydig cell tumors represent about 0.2 to 0.5% of all primary ovarian tumors. One of the main features of this type of tumor is the high production of androgens, which promotes hirsutism and virilization. This case reports a 28-year-old patient with severe abdominal pain whose physical examination showed a right adnexal mass, confirmed by pelvic US, without clinical evidence of virilization, who presented elevated alpha-fetoprotein (636 ng/mL), negative hCG-β and was negative to other tumor markers. Exploratory laparotomy was performed with right salpingo-oophorectomy. Histologically, it was identified a tumor with het erogeneous areas, retiform, tubular, microcystic, anastomosing cords and trabeculae with Ley dig cells and areas of hepatoid differentiation. The tumor was positive for inhibin, cytokeratin AE1/AE3 and calretinin. One week after surgery, alpha-feto protein levels dropped to 150 ng/ml and to 0.89 ng/ml five months later. This is a case of Sertoli-Leydig cell tumor with elevated alpha fetoprotein no evidence of virilization and the histological pattern showing focal areas of hepatoid differentiation.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Gynecology and Obstetrics Research (GOR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.